Xeris Pharmaceuticals | XERS - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Celltrion KRW 301.04B 58.57B 2025-09
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Nektar Therapeutics USD -34.34M 15.43M 2024-09
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organigram Holdings CAD -28.05M 7.76M 2025-09
Ovoca Bio EUR -5.65M 3.45M 2022-06
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pharma Mar EUR 43.61M 47.57M 2025-12
Qiagen NV USD 121.88M 15.41M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Tilray USD -20.01M 9.34M 2025-09
Zz Pientze Pharmaceu CNY 501.33M 52.54M 2025-09